Abstract
Introduction: Chronic liver disease is labeled as a classic acquired bleeding disorder, however it has been demonstrated that these patients present thrombin production within normal range, which raises questions about the International Normalized Ration included in several prognosis stratification scores. Although this population does not seem to be protected from thrombotic events, the prophylaxis of deep vein thrombosis is mostly withheld from patients with chronic liver disease. Objectives: Our aim is to analyze the incidence of thrombotic events and the percentage of prophylaxis use in in-patients with diagnosis chronic liver disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
